{"id":2282,"date":"2023-07-04T08:09:00","date_gmt":"2023-07-04T08:09:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=2282"},"modified":"2023-07-05T08:09:37","modified_gmt":"2023-07-05T08:09:37","slug":"first-ai-generated-drug-given-go-ahead-for-human-trials","status":"publish","type":"post","link":"https:\/\/dailyai.com\/pt\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","title":{"rendered":"Primeiro medicamento gerado por IA recebe luz verde para ensaios em seres humanos"},"content":{"rendered":"<p><strong>A Insilico Medicine recebeu aprova\u00e7\u00e3o para ensaios em humanos do seu medicamento totalmente gerado por IA.<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">O medicamento foi concebido como um potencial tratamento para a fibrose pulmonar idiop\u00e1tica (FPI), uma doen\u00e7a degenerativa que provoca a forma\u00e7\u00e3o de cicatrizes e o espessamento dos tecidos pulmonares. A FPI afecta cerca de 100 000 pessoas s\u00f3 nos EUA. O novo medicamento, denominado INS018_055, ser\u00e1 testado durante 12 semanas na China, estando previstos ensaios alargados \u00e0 China e aos EUA.<\/span><\/p>\n<p><a href=\"https:\/\/insilico.com\/\"><span style=\"font-weight: 400;\">Insilico<\/span><\/a><span style=\"font-weight: 400;\"> \u00e9 uma empresa de biotecnologia sediada em Hong Kong que utiliza a IA para desenvolver novos medicamentos, bem como na investiga\u00e7\u00e3o anti-envelhecimento. A aplica\u00e7\u00e3o da IA na sua investiga\u00e7\u00e3o permitiu um desenvolvimento muito mais r\u00e1pido de novos medicamentos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A IA permite-nos analisar quantidades maci\u00e7as de dados e encontrar liga\u00e7\u00f5es que os cientistas humanos podem n\u00e3o ver e, em seguida, \"imaginar\" mol\u00e9culas totalmente novas que podem ser transformadas em medicamentos\", afirmou Alex Zhavoronkov, fundador e diretor executivo da Insilico Medicine.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A empresa utiliza a IA em cada etapa da sua estrat\u00e9gia de desenvolvimento de medicamentos. Em primeiro lugar, utilizam a sua ferramenta baseada em IA, denominada PandaOmics, para identificar um \"alvo\" ou uma causa biol\u00f3gica associada a uma doen\u00e7a espec\u00edfica. Por exemplo, o alvo pode ser um gene ou uma prote\u00edna que n\u00e3o esteja a funcionar corretamente.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Assim que identificam um alvo, utilizam a sua outra plataforma de IA, a Chemistry42, para conceber uma mol\u00e9cula que rectifique o problema, bloqueando o alvo sem causar danos ao doente.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Neste caso, o \"55\" no nome do medicamento refere-se \u00e0 55\u00aa mol\u00e9cula que foi concebida e se revelou promissora.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Os ensaios de Fase II que foram aprovados t\u00eam como objetivo verificar se o medicamento produz uma resposta significativa nos primeiros participantes. Se for bem sucedido, passar\u00e1 ent\u00e3o aos ensaios de Fase III para confirmar a seguran\u00e7a e a efic\u00e1cia antes de poder ser aprovado pela FDA.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A Insilico Medicine tem na calha uma s\u00e9rie de desenvolvimentos interessantes em mat\u00e9ria de medicamentos com IA. A FDA aprovou recentemente o pedido inicial de investiga\u00e7\u00e3o de um novo medicamento (IND) para o seu medicamento anti-cancro que visa tumores s\u00f3lidos. Os ensaios de fase I est\u00e3o planeados para julho de 2023 nos EUA e na China.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Quando ouvimos falar de IA generativa, pensamos normalmente na gera\u00e7\u00e3o de imagens, can\u00e7\u00f5es ou texto. Mas a Insilico est\u00e1 a utilizar a IA generativa para identificar os alvos que causam uma doen\u00e7a e, em seguida, conceber mol\u00e9culas que se dirigem diretamente a esses alvos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Se perguntarmos ao ChatGPT quais as prote\u00ednas que podem ser utilizadas para tratar um tipo espec\u00edfico de cancro da mama, ele poder\u00e1 identific\u00e1-las porque tem acesso \u00e0 investiga\u00e7\u00e3o m\u00e9dica publicada. A Insilico tem o seu pr\u00f3prio LLM, denominado ChatPandaGPT, que permite aos investigadores utilizar consultas em linguagem natural para analisar uma base de conhecimentos especializados de grandes quantidades de dados cl\u00ednicos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Utilizar <\/span><a href=\"https:\/\/dailyai.com\/pt\/2023\/06\/researchers-create-high-performance-ai-model-to-detect-heart-disease-from-ecgs\/\"><span style=\"font-weight: 400;\">IA na medicina<\/span><\/a><span style=\"font-weight: 400;\"> est\u00e1 a ajudar empresas como a Insilico a encurtar drasticamente o processo de descoberta de medicamentos. Os seus <\/span><a href=\"https:\/\/insilico.com\/pipeline\"><span style=\"font-weight: 400;\">linha de investiga\u00e7\u00e3o<\/span><\/a><span style=\"font-weight: 400;\"> tem uma linha interessante de potenciais tratamentos para diferentes tipos de cancro, bem como um medicamento para a COVID-19 que tamb\u00e9m est\u00e1 em fase de ensaios de Fase I.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>A Insilico Medicine recebeu aprova\u00e7\u00e3o para ensaios em humanos do seu medicamento totalmente gerado por IA. O medicamento foi concebido como um potencial tratamento para a fibrose pulmonar idiop\u00e1tica (FPI), uma doen\u00e7a degenerativa que provoca a forma\u00e7\u00e3o de cicatrizes e o espessamento dos tecidos pulmonares. A FPI afecta cerca de 100 000 pessoas s\u00f3 nos EUA. O novo medicamento, denominado INS018_055, ser\u00e1 testado durante 12 semanas na China, estando previstos ensaios alargados \u00e0 China e aos EUA. A Insilico \u00e9 uma empresa de biotecnologia sediada em Hong Kong que utiliza a IA para desenvolver novos medicamentos, bem como na investiga\u00e7\u00e3o anti-envelhecimento. A aplica\u00e7\u00e3o da IA na sua<\/p>","protected":false},"author":6,"featured_media":2283,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84],"tags":[150,107,101],"class_list":["post-2282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-ai-benefits","tag-generative-ai","tag-medtech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First AI-generated drug given go-ahead for human trials | DailyAI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/pt\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First AI-generated drug given go-ahead for human trials | DailyAI\" \/>\n<meta property=\"og:description\" content=\"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/pt\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-04T08:09:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-05T08:09:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Eugene van der Watt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eugene van der Watt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"author\":{\"name\":\"Eugene van der Watt\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\"},\"headline\":\"First AI-generated drug given go-ahead for human trials\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"wordCount\":479,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"keywords\":[\"AI benefits\",\"Generative AI\",\"MedTech\"],\"articleSection\":[\"Industry\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"name\":\"First AI-generated drug given go-ahead for human trials | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"width\":1000,\"height\":563,\"caption\":\"AI generated drug gets human trial approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First AI-generated drug given go-ahead for human trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\",\"name\":\"Eugene van der Watt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"caption\":\"Eugene van der Watt\"},\"description\":\"Eugene comes from an electronic engineering background and loves all things tech. When he takes a break from consuming AI news you'll find him at the snooker table.\",\"sameAs\":[\"www.linkedin.com\\\/in\\\/eugene-van-der-watt-16828119\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/pt\\\/author\\\/eugene\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Primeiro medicamento gerado por IA com luz verde para ensaios em humanos | DailyAI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/pt\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_locale":"pt_PT","og_type":"article","og_title":"First AI-generated drug given go-ahead for human trials | DailyAI","og_description":"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their","og_url":"https:\/\/dailyai.com\/pt\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_site_name":"DailyAI","article_published_time":"2023-07-04T08:09:00+00:00","article_modified_time":"2023-07-05T08:09:37+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","type":"image\/jpeg"}],"author":"Eugene van der Watt","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Escrito por":"Eugene van der Watt","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"author":{"name":"Eugene van der Watt","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa"},"headline":"First AI-generated drug given go-ahead for human trials","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"wordCount":479,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","keywords":["AI benefits","Generative AI","MedTech"],"articleSection":["Industry"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","url":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","name":"Primeiro medicamento gerado por IA com luz verde para ensaios em humanos | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","breadcrumb":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","width":1000,"height":563,"caption":"AI generated drug gets human trial approval"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"First AI-generated drug given go-ahead for human trials"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"A sua dose di\u00e1ria de not\u00edcias sobre IA","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa","name":"Eugene van der Watt","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","caption":"Eugene van der Watt"},"description":"Eugene vem de uma forma\u00e7\u00e3o em engenharia eletr\u00f3nica e adora tudo o que \u00e9 tecnologia. Quando faz uma pausa no consumo de not\u00edcias sobre IA, pode encontr\u00e1-lo \u00e0 mesa de snooker.","sameAs":["www.linkedin.com\/in\/eugene-van-der-watt-16828119"],"url":"https:\/\/dailyai.com\/pt\/author\/eugene\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/posts\/2282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/comments?post=2282"}],"version-history":[{"count":1,"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/posts\/2282\/revisions"}],"predecessor-version":[{"id":2284,"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/posts\/2282\/revisions\/2284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/media\/2283"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/media?parent=2282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/categories?post=2282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/pt\/wp-json\/wp\/v2\/tags?post=2282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}